Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins)

Submitted by Anonymous on

Dizal logo (PRNewsfoto/Dizal Pharmaceutical) By Dizal This content is provided by PR Newswire. For questions or concerns, please contact them directly at prncs@cision.com. Treatment with ZEGFROVY® resulted in statistically significant and clinically meaningful improvement in progression free survival (PFS) over...

Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins)

Submitted by Anonymous on

Treatment with ZEGFROVY® resulted in statistically significant and clinically meaningful improvement in progression free survival (PFS) over platinum-containing chemo doublet WU-KONG 28 is the first and only phase 3 study to demonstrate meaningful benefits with an oral, once daily, chemo-free,...

Microwave-Accelerated C─N Coupling for the Efficient Synthesis of Triazolo[4,3-b]Pyridazine Derivatives With Potent Cytotoxic Activity and EGFR Inhibitory Potential

Submitted by Anonymous on

ChemistrySelectVolume 11, Issue 12 e06368 RESEARCH ARTICLE Microwave-Accelerated C─N Coupling for the Efficient Synthesis of Triazolo[4,3-b]Pyridazine Derivatives With Potent Cytotoxic Activity and EGFR Inhibitory Potential Krishna Ranjith Kumar, Krishna Ranjith Kumar Department of Chemistry, Vidya Vikas Institute of Engineering &...

Microwave-Accelerated C─N Coupling for the Efficient Synthesis of Triazolo[4,3-b]Pyridazine Derivatives With Potent Cytotoxic Activity and EGFR Inhibitory Potential

Submitted by Anonymous on

ChemistrySelectVolume 11, Issue 12 e06368 RESEARCH ARTICLE Microwave-Accelerated C─N Coupling for the Efficient Synthesis of Triazolo[4,3-b]Pyridazine Derivatives With Potent Cytotoxic Activity and EGFR Inhibitory Potential Krishna Ranjith Kumar, Krishna Ranjith Kumar Department of Chemistry, Vidya Vikas Institute of Engineering &...

Disparities in Kidney Disease and the Race-Neutral eGFR - Research and Action in NYC’s Public Hospital System

Submitted by Anonymous on

The race-adjusted estimated glomerular filtration rate reduced Black patients’ access to kidney transplants. NYC Health+Hospitals is studying the effect of a race-neutral algorithm PerspectiveEfforts toward Equity Share on Disparities in Kidney Disease and the Race-Neutral eGFR - Research and Action...

Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study

Submitted by Anonymous on

AbstractBackground The optimal treatment strategy for epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer (NSCLC)-sequential tyrosine kinase inhibitor (TKI) monotherapies versus upfront combination therapies-remains debated. Objective The Giotrif In Advanced NSCLC Taiwan (GIANT) study evaluated the real-world outcomes...

Coronavirus disease 2019 infection reduces EGFR-TKI efficacy in non-small cell lung carcinoma: Real-world evidence from a multicenter propensity-matched cohort

Submitted by Anonymous on

Lung cancer patients with COVID-19 experience significantly increased risk for severe illness and mortality. However, research addressing the effect of COVID-19 on non-small cell lung cancer (NSCLC) 1 INTRODUCTION Since the discovery of epidermal growth factor receptor (EGFR) mutations in...

Subscribe to Newsfeed